News

BioSpace29m
AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
AstraZeneca beats second-quarter profit expectations, maintains outlook
AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney ...
AstraZeneca share price forecast after earnings
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
AstraZeneca beats forecasts after record US growth
AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business.
Fierce Biotech8h
AstraZeneca drops lead T-cell receptor therapy from $200M Neogene buy
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
Explore more
UK-listed AstraZeneca: ‘We are a very American company’
AstraZeneca’s chief executive has said the drugmaker is a “very American company” amid growing speculation it will shift its ...
AstraZeneca Stock Rises as US, Cancer Drugs Growth Lifts Q2 Results
AstraZeneca shares are rising in premarket trading Tuesday after the pharma giant beat second-quarter estimates on strong U.S ...
AstraZeneca tops expectations on robust drug sales, US demand
AstraZeneca on Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney ...
AstraZeneca Books Record Quarterly Revenue as Oncology Boosts Growth
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. Revenue in its oncology ...